google ads

Imaging Review of Vasculitis

Imaging Review of Vasculitis

Franco Verde, MD; Elliot K Fishman, MD

 

Disclosures

None of the authors have any relevant disclosures

 

Outline

A. Introduction
B. CHCC2012 Nomenclature
C. CHCC2012 Definition and Cases
D. Selected Clinical Summaries
E. Clinical Approach
F. Role of Imaging
G. Summary

 

Introduction

  • In 2012, the International Chapel Hill Consensus Conference (CHCC2012) on the Nomenclature of Systemic Vasculitides met to revised the first Conference in 1994.
  • The Conference defined the major categories, vasculitides under those categories, and more appropriate names whenever possible (i.e. to remain eponymous or non-eponymous)

 

Introduction

  • Vasculitis is inflammation of the blood vessel walls, which is a shared defining feature of all categories of vasculitis
  • Features that vary among different forms of vasculitis and can be used for categorization include etiology, pathogenesis, type of vessel affected, type of inflammation, favored organ distribution, clinical manifestations, genetic predispositions, and distinctive demographic characteristics
  • Vasculitides can be broadly dichotomized into infectious vasculitis, known to be caused by direct invasion and proliferation of pathogens in vessel walls with resultant inflammation, versus noninfectious vasculitis, not known to be caused by direct vessel wall invasion by pathogens.
    • For example cryoglobulinemic vasculitis caused by autoimmune response initiated by hepatitis C virus would be a non-infectious vasculitis compared to Aspergillus arteritis which directly invades and proliferates in the vascular wall

 

Overall CHCC2012 Nomenclature

CHCC categorizes non-infectious vasculitis into
  • Large vessel vasculitis (LVV): affecting large arteries more often than other vasculitides
  • Medium vessel vasculitis (MVV): predominately affecting medium arteries defined as main visceral arteries and their branches
  • Small vessel vasculitis (SVV): predominately affecting small vessels defined as small intraparenchymal arteries, arterioles, capillaries, and venules
  • Variable vessel vasculitis (VVV): no predominate type of vessel involved
  • Single organ vasculitis (SOV): arteries or veins of any size in a single organ
  • Vasculitis associated with systemic disease: considered a secondary vasculitis with the systemic disease as prefix
  • Vasculitis associated with probable etiology: similar to the former but the etiology is known compared to systemic disease where the etiology is not known

 

CHCC2012 definitions and cases

LVV: Takayasu (TAK) and Giant cell arteritis (GCA)
  • TAK: Arteritis, often granulomatous, predominantly affecting the aorta and/or its major branches. Onset usually in patients younger than 50 years
  • GCA: Arteritis, often granulomatous, usually affecting the aorta and/or its major branches, with a predilection for the branches of the carotid and vertebral arteries. Often involves the temporal artery. Onset usually in patients older than 50 years and often associated with polymyalgia rheumatica.

 

Takayasu Arteritis

Figure 1. 32 year old white woman presenting with a cold arm. Non-contrast MR imaging of the chest with axial T1 darkblood (A) and axial T2 darkblood fat-suppressed sequences. Note subtle cuff of aortic wall thickening on T1 sequence (yellow arrow) with associated T2 hyperintensity. Finding raises concern for large-vessel vasculitis (Takayasu or Giant cell) or possibly medium-vessel (i.e. Kawasaki) or variable-vessel vasculitis (Bechet's) that also affects the aorta. Takayasu affects women in 80-90 percent of cases, with onset between 10-40 years. Giant-cell affects the aorta and branches but almost never occurs before 50 years old. Kawasaki disease rarely occurs in adults.

Takayasu Arteritis

 

Giant cell Arteritis

Figure 2. 68 year old woman with fatigue, mild frontal headaches, ear pain and congestion for past month. Elevated sedimentation rate of 98 with anemia. Dental exam was normal. No response to antibiotics for possible sinusitis. Eye exam was normal. Vasculitis was suspected. IV contrast enhanced CT of the chest in axial (A) and coronal (B) planes demonstrate subtle diffuse thickening of the aorta and great vessels compatible with a large vessel vasculitis. Temporal artery biopsy was positive for lymphocytic infiltrate. Findings are compatible with giant cell arteritis with this constellation of clinical findings, other negative work up, positive laboratory values, and positive temporal artery biopsy.

Giant cell Arteritis

 

CHCC2012 definitions and cases

MVV: Polyarteritis nodosa (PAN) and Kawasaki disease (KD)
  • PAN: Necrotizing arteritis of medium or small arteries without glomerulonephritis or vasculitis in arterioles, capillaries, or venules, and not associated with antineutrophil cytoplasmic antibodies (ANCAs).
  • KD: Arteritis associated with the mucocutaneous lymph node syndrome and predominantly affecting medium and small arteries. Coronary arteries are often involved. Aorta and large arteries may be involved. Usually occurs in infants and young children.

 

Polyarteritis nodosa

Figure 3. 55 year old man with renal failure and hypertension. IV contrast enhanced CT of the abdomen with MIP reformatted images demonstrates stricturing and microaneurysm formation of multiple right hepatic artery branches (A, yellow circle and D, yellow arrow). Extensive renal artery infarcts noted (B, yellow circle and C, yellow arrow). Multi-organ involvement of medium-size vessels in a middle age man is commonly polyarteritis nodosa. The kidney is the most commonly involved organ.

Polyarteritis nodosa

 

Polyarteritis nodosa

Figure 4. 37 year old man with chronic medium-vessel vasculitis diagnosed 8 year prior with mononeuritis multiplex, digital ischemia status post amputations, mesenteric vasculitis, elevated RF factor, and negative ANCA. Catheter based angiogram of the superior mesenteric vessels (A) demonstrates multifocal structuring of the SMA branches (A, yellow arrows). Followup IV contrast enhanced CT performed 1 month later (B and C) demonstrates persistent multifocal narrowing of the SMA (B, C yellow arrows). Note the superior resolution of the angiogram compared to CT. Given constellation of findings, patient was diagnosed with PAN and treated with steroids and cytotoxic agents.

Polyarteritis nodosa

 

Kawasaki disease

Figure 5. 53 year old man presenting with chest pain. Coronary CT angiogram demonstrates a 10 mm fusiform aneurysmal dilation of the right coronary artery. Patient has a history of Kawasaki disease as a child. Coronary aneurysms are common complications with KD. Children can present with self-limiting fever, lip and tongue erythema and swelling, rash, cervical adenopathy, hand and foot erythema. Complications include myocardial suppression causing shock, macrophage activation syndrome, cardiac valvular disease, PAD, sensorineural hearing loss, and GI abnormalities (ileus, bowel inflammation).

Kawasaki disease

 

CHCC2012 definitions and cases

SVV:
  • ANCA-associated vasculitis (AAV): Necrotizing vasculitis, with few or no immune deposits, predominantly affecting small vessels (i.e., capillaries, venules, arterioles, and small arteries), associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA. Not all patients have ANCA. Add a prefix indicating ANCA reactivity, e.g., MPO-ANCA, PR3-ANCA, ANCA-negative
  • Microscopic polyangiitis (MPA): Necrotizing vasculitis, with few or no immune deposits, predominantly affecting small vessels (i.e., capillaries, venules, or arterioles). Necrotizing arteritis involving small and medium arteries may be present. Necrotizing glomerulonephritis is very common. Pulmonary capillaritis often occurs. Granulomatous inflammation is absent
  • Granulomatosis with polyangiits (Wegener’s) (GPA): Necrotizing granulomatous inflammation usually involving the upper and lower respiratory tract, and necrotizing vasculitis affecting predominantly small to medium vessels (e.g., capillaries, venules, arterioles, arteries and veins). Necrotizing glomerulonephritis is common.

 

Granulomatosis with polyangiitis (Wegener’s) (GPA)

Figure 6. 20 year old man with shortness of breath and productive cough for past two days. Additional hemoptysis appearing since yesterday. Additional history reveals a 3 month history of sinusitis and epistaxis. Additional labs reveals acute renal failure, markedly elevated ESR and CRP, leukocytosis, and hematuria. ANA and cANCA were positive. No eosinophilia. Non-contrast CT in axial (A) and coronal (B) planes demonstrates extensive upper and lower lobe nodular and confluent consolidations, consistent with alveolar hemorrhage. Kidney biopsy was performed with acute necrotizing crescentic glomerulonephritis. Constellation of findings is consistent with granulomatosis with polyangiitis (Wegener’s) (GPA).

Granulomatosis with polyangiitis (Wegener’s) (GPA)

 

CHCC2012 definitions and cases

SVV:
  • Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA): Eosinophil-rich and necrotizing granulomatous inflammation often involving the respiratory tract, and necrotizing vasculitis predominantly affecting small to medium vessels, and associated with asthma and eosinophilia. ANCA is more frequent when glomerulonephritis is present.
  • Immune complex vasculitis: Vasculitis with moderate to marked vessel wall deposits of immunoglobulin and/or complement components predominantly affecting small vessels (i.e., capillaries, venules, arterioles, and small arteries). Glomerulonephritis is frequent.
  • Anti–glomerular basement membrane (anti-GBM) disease: Vasculitis affecting glomerular capillaries, pulmonary capillaries, or both, with GBM deposition of anti-GBM autoantibodies. Lung involvement causes pulmonary hemorrhage, and renal involvement causes glomerulonephritis with necrosis and crescents.

 

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA)

Figure 7. 58 year old woman with history of allergies and recurrent sinusitis for the past 6 years. Patient presents with worsening cough. Initial scan demonstrates a large thick-walled cavitary mass in the superior segment of the right lower lobe. Mass was resected demonstrating a marked eosinophilic infiltration. No signs of malignancy or infection was seen. Patient returns 6 months later with a similar cavitary mass in the posterior right upper lobe. Clinical and imaging findings are compatible with eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA).

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA)

 

Anti–glomerular basement membrane (anti-GBM) disease

Figure 8. 23 year old man with fever, cough, and recurrent hemoptysis for 1 month and increasing dyspnea for past week. Urinalysis demonstrated proteinuria and hematuria. Anti-GBM antibodies were present. Chest radiograph (A) demonstrates bilateral opacities, right more than left with normal heart size and no effusions. Follow-up chest CT (B) demonstrates bilateral, right more than left, consolidations with ground glass opacities. Constellation of findings are compatible with diffuse alveolar hemorrhage secondary to anti–glomerular basement membrane (anti-GBM) disease.

Anti–glomerular basement membrane (anti-GBM) disease

 

CHCC2012 definitions and cases

SVV:
  • Cryoglobulinemic vasculitis (CV): Vasculitis with cryoglobulin immune deposits affecting small vessels (predominantly capillaries, venules, or arterioles) and associated with serum cryoglobulins. Skin, glomeruli, and peripheral nerves are often involved.
  • IgA vasculitis (Henoch-Schonlein) (IgAV): Vasculitis, with IgA1-dominant immune deposits, affecting small vessels (predominantly capillaries, venules, or arterioles). Often involves skin and gastrointestinal tract, and frequently causes arthritis. Glomerulonephritis indistinguishable from IgA nephropathy may occur.
  • Hypocomplementemic urticarial vasculitis (HUV) (anti-C1q vasculitis): Vasculitis accompanied by urticaria and hypocomplementemia affecting small vessels (i.e., capillaries, venules, or arterioles), and associated with anti-C1q antibodies. Glomerulonephritis, arthritis, obstructive pulmonary disease, and ocular inflammation are common.

 

IgA vasculitis (Henoch-Schonlein) (IgAV)

Figure 9. Two different patients both presenting with abdominal pain, a 20 year old man and a 5 year old girl. Patient in figure A demonstrates diffuse small bowel enhancement and wall thickening (A, yellow arrows). Second patient in figure B demonstrates circumferential small bowel edema involvemed in a small bowel intussusception on transabdominal sonogram. Both patients were diagnosed with IgA vasculitis (Henoch-Schonlein) (IgAV), which is more typical in children. Children usually present with cutaneous purpura, abdominal pain, hematuria, and joint pain.

IgA vasculitis (Henoch-Schonlein) (IgAV)

 

CHCC2012 definitions and cases

VVV: Behcet’s disease and Cogan’s syndrome
  • Behcet’s disease: characterized by recurrent oral and/or genital aphthous ulcers accompanied by cutaneous, ocular, articular, gastrointestinal, and/or central nervous system inflammatory lesions. Small vessel vasculitis, thromboangiitis, thrombosis, arteritis, and arterial aneurysms may occur.
  • Cogan’s syndrome: characterized by ocular inflammatory lesions, including interstitial keratitis, uveitis, and episcleritis, and inner ear disease, including sensorineural hearing loss and vestibular dysfunction. Vasculitic manifestations may include arteritis (affecting small, medium, or large arteries), aortitis, aortic aneurysms, and aortic and mitral valvulitis.

 

Behcet’s disease

Figure 10. 54 year old middle eastern man presents for evaluation of renal mass (not shown). Patient has a long standing history of Bechet’s disease diagnosed 20 years ago. IV contrast enhanced CT images of the chest and abdomen were obtained. Subtle thickening of the aortic arch is seen (A, yellow arrow). Evidence of chronic thrombosis of the infrarenal aorta is also shown (B, yellow arrow) with well-developed body wall collaterals (C, yellow arrows).

Behcet’s disease

 

Hughes-Stovin syndrome

Figure 11. 23 year old with chronic abdominal pain, chest pain, and recurrent GI bleeds, recent hospitalization for bilateral PE, currently being worked up for Behcet's, on methotrexate, s/p central line placement prior to discharge for dilaudid PCA, TPN, and antiemetics at home in the setting or oral intolerance, presents with concern for infection at site of her central line. IV contrast enhanced CT of the chest in axial (A) and axial MIP (B) images demonstrates bilateral lower lobe pulmonary emboli (A, yellow arrows) with proximal left main artery stenosis with aneurysmal dilation (B, red arrows). Patient lacked the other typical findings with Behcet’s and was diagnosed with Hughes-Stovin syndrome which is considered a forme fruste or incomplete variant of Behcet’s disease.

Hughes-Stovin syndrome

 

CHCC2012 definitions and cases

  • SOV: Vasculitis in arteries or veins of any size in a single organ that has no features that indicate that it is a limited expression of a systemic vasculitis. The involved organ and vessel type should be included in the name (e.g., cutaneous small vessel vasculitis, testicular arteritis, central nervous system vasculitis). Vasculitis distribution may be unifocal or multifocal (diffuse) within an organ. Some patients originally diagnosed as having SOV will develop additional disease manifestations that warrant redefining the case as one of the systemic vasculitides (e.g., cutaneous arteritis later becoming systemic polyarteritis nodosa, etc.).
  • Vasculitis associated with systemic disease: Vasculitis that is associated with and may be secondary to (caused by) a systemic disease. The name (diagnosis) should have a prefix term specifying the systemic disease (e.g., rheumatoid vasculitis, lupus vasculitis, etc.).
  • Vasculitis associated with probable etiology: Vasculitis that is associated with a probable specific etiology. The name (diagnosis) should have a prefix term specifying the association (e.g., hydralazine-associated microscopic polyangiitis, hepatitis B virus–associated vasculitis, hepatitis C virus–associated cryoglobulinemic vasculitis, etc.).

 

Clinical Approach

  • It is not possible to develop a single algorithm for evaluating suspected vasculitis due to the heterogeneity of these diseases
  • Vasculitis should be considered in patients who present with systemic or constitutional symptoms in combination with evidence of single or multi-organ dysfunction
    • Delay of diagnosis is common secondary to clinical manifestations mimicking many other diseases
  • Patients often present with fever, fatigue, weight loss, and arthralgia
  • Particular clinical symptoms may also clue into vasculitis such as eye inflammation, upper airway chronic inflammation, motor neuropathy, limb claudication in patients low risk for atherosclerosis, unexplained hemoptysis, combined lung and renal symptoms
  • Evaluating for systemic diseases and medication uses is helpful for diagnosing a vasculitis due to a systemic disease or associated with a particular etiology
  • Patients age and sex is also useful for evaluation, for example in one large series:
    • IgA vasculitis: mean age 17, 46% female
    • Giant cell arteritis: mean age 69, 75% female
    • Takayasu arteritis: mean age 26, 86% female
    • EGA: mean age 50, 37% female

 

Clinical Approach

Laboratory tests:
  • Some laboratory tests may help identify the type of vasculitis, the degree of organ involvement, or identify another disease.
  • Initial evaluation should include a CBC, chemistry, LFTs, ESR and/or CRP, serologies for viral hepatitis, serum cryoglobulins, and a urinalysis with urinary sediment. Blood cultures should be drawn to help exclude infection (e.g., infective endocarditis).
  • Antinuclear antibody (ANA) may support the presence of lupus
  • Low complement levels, especially C4 may be present in mixed cryoglobulinemia and lupus but not other vasculitides
  • ANCA against protease 3 or myeloperoxidase is extremely specific for diagnosing AAV when vasculitis is suspected

 

Selected Clinical Summaries

Takayasu:
  • Women (~90% of cases), 10-40 years, typically seen in Asians
  • Presents with fatigue, weight loss, fever, and synovitis
  • Symptoms associated with the large vessel involved:
    • Subclavian, axial, femoral artery involvement can cause cool extremities, pain, claudication, ischemia, subclavian steal syndrome
    • Pulmonary involvement can cause chest pain, dyspnea, hemoptysis, pHTN, heart failure
    • Carotid and vertebral artery involvement can cause vertigo, syncope, headache, seizures, vascular dementia
    • Mesenteric involvement can cause abdominal pain, diarrhea, hemorrhage
    • Coronary ostial involvement can cause myocardial infarctions and angina

 

Selected Clinical Summaries

Giant cell arteritis:
  • Women > men, 3 to 1, 80% of cases over 70 (mean 77)
    • High incidence in Scandinavian descent, unusual in Latinos, Asians, AAs
  • Presents with fatigue, weight loss, fever, synovitis
    • Headache occurs in > two thirds of cases with scalp tenderness
    • Rapid onset of jaw claudication after chewing
    • Temporary and permanent vision loss
  • Similar to Takayasu arteritis, involvement of aorta and branches is common and can cause similar symptoms
  • Respiratory symptoms can be presents with cough with involvement of the bronchial arteries

 

Selected Clinical Summaries

Polyarteritis nodosa
  • Rare, 2 to 33 per million, middle to older adults with peak in sixth decade of life, 1.5:1 male predominance
  • Presents with typical constitutional symptoms (fatigue, weakness, fever, and arthralgia)
  • Essentially any organ can be involved due to medium to small vasculitis
  • Skin manifestation are common with tender erythematous nodules
  • Kidneys are most commonly involved with renal insufficiency, hypertension, renal artery aneurysms, hematuria
  • Neurologic manifestations are common include mononeuropathy multiplex or asymmetric polyneuropathy
  • GI symptoms with pain, intestinal angina. Perforation during colonoscopy is common. Rarely cystic or appendiceal arteritis can resemble acute cholecystitis and appendicitis
  • Coronary involvement can cause myocardial infarctions
  • Muscular involvement with pain and weakness

 

Selected Clinical Summaries

GPA and MPA
  • Similar clinical overlap
  • Occur commonly in older adults without sex predilection, 90% of patients are white
  • Common constitutional symptoms (fever, weight loss, arthralgia, and malaise)
  • Ear, nose, throat symptoms (sinusitis, otitis, otorrhea, epistasis, ulcers, hearing loss, nasal deformity) are more common in GPA over MPA
  • Pulmonary airway involvement is common with cough, stridor, hemoptysis, pleurisy, subglottic stenosis. Lung involvement is seen with nodules, consolidation
  • Renal involvement is common with glomerulonephritis in up to 85% of cases within first two years of onset
  • Additional involvement include cutaneous, ophthalmic, and nervous system abnormalities

 

Selected Clinical Summaries

Eosinophilic granulomatosis with polyangiitis
  • Mean age of 40 years, without sex predilection, rare in children
  • 3 sequential phases:
    • Prodromal: 2nd and 3rd decades with atopy, asthma, allergic rhinitis
    • Eosinophilic: infiltration into lung and GI tract
    • Vasculitic: 3rd and 4th decades
  • Asthma is a cardinal clinical feature which can be difficult to manage. Additional lung findings include nodules, consolidations which can cavitate, alveolar hemorrhage
  • Upper airway and ear disease can be seen in up to 50 percent of cases with otitis, rhinitis, sinusitis, and nasal polyposis
  • Skin involvement manifests as granulomatosis nodules of the arms, elbows, hands and legs
  • Cardiac involvement can cause heart failure
  • DVTs can occur
  • Mononeuritis multiplex is seen in up to 75 percent of cases
  • Eosinophilic gastroenteritis can be seen with pain, diarrhea, and bleeding

 

Role of Imaging

  • High-resolution computed tomography (HRCT) of the chest is indicated in patients with respiratory symptoms and/or hemoptysis.
  • Vascular imaging — Magnetic resonance imaging (MRI), MR angiograms, CT angiograms, and vascular ultrasound may be used to detect large artery lesions and, especially CT and MRI, have become the standard approach to screening for large-vessel vasculitis.
  • However, while more invasive imaging studies generally can be avoided, conventional catheter-based angiography remains an important diagnostic test in some situations. The presence of angiographic abnormalities are not pathognomonic for vasculitis, but they can be used to support a diagnosis when combined with other clinical data.
  • By contrast, angiography is unlikely to be helpful in assessing a small-vessel vasculitis because the affected vessels are below the resolution of usual angiograms.

 

Role of Imaging

Optimizing CT protocol
  • Suspected vasculitis should be performed with arterial and venous phase to evaluate for large and medium artery vasculitides
  • Studies should be done according to ALARA principle
  • Dose reduction techniques include automatic modulation of mAs and kVp according to body habitus.
  • Dual energy techniques can be utilized for bone removal to generate high quality vascular maps
  • Water as a negative oral contrast agent is preferred when evaluating the mesenteric vasculature or bowel involvement

 

References

  • Jenette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis & Rheumatism 2013 65(1):1-11.
  • Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990 33(8):1065-7.
  • Merkel PA. Overview of and approach to the vasculitides in adults. UpToDate 2013 Noris M, Daina E, Gamba S, et al. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 1999; 100:55.
  • Yoneda S, Nukada T, Tada K, et al. Subclavian steal in Takayasu's arteritis. A hemodynamic study by means of ultrasonic Doppler flowmetry. Stroke 1977; 8:264.
  • Nakabayashi K, Kurata N, Nangi N, et al. Pulmonary artery involvement as first manifestation in three cases of Takayasu arteritis. Int J Cardiol 1996; 54 Suppl:S177.
  • Rodríguez-Pla A, de Miguel G, López-Contreras J, et al. Bilateral blindness in Takayasu's disease. Scand J Rheumatol 1996; 25:394.
  • Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med 1994; 120:919.

 

References

  • Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, et al. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005; 84:269.
  • Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981; 24:1414.
  • Knockaert DC, Vanneste LJ, Bobbaers HJ. Fever of unknown origin in elderly patients. J Am Geriatr Soc 1993; 41:1187.
  • Jones JG. Clinical features of giant cell arteritis. Baillieres Clin Rheumatol 1991; 5:413.
  • Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996; 35:1161.
  • Watts RA, Lane SE, Scott DG, et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001; 60:1156.
  • Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000; 43:414.

 

References

  • Watts RA, Gonzalez-Gay MA, Lane SE, et al. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 2001; 60:170.
  • Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005; 84:313.
  • Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337:1512.
  • Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004; 117:39.
  • Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 1990; 113:656.
  • Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984; 63:65.
  • Pagnoux C, Guillevin L. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 2010; 22:21.

 

References

  • Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013; 65:270.
  • Cottin V, Khouatra C, Dubost R, et al. Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up. Allergy 2009; 64:589.
  • Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998; 279:455.

Privacy Policy

Copyright © 2024 The Johns Hopkins University, The Johns Hopkins Hospital, and The Johns Hopkins Health System Corporation. All rights reserved.